$Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab$

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood cancer journal (New York) 2020-09, Vol.10 (9), p.92, Article 92
Hauptverfasser:	Gentile, Massimo, Martino, Enrica Antonia, Visentin, Andrea, Coscia, Marta, Reda, Gianluigi, Sportoletti, Paolo, Mauro, Francesca Romana, Laurenti, Luca, Varettoni, Marzia, Murru, Roberta, Chiarenza, Annalisa, Vigna, Ernesto, Mendicino, Francesco, Lucia, Eugenio, Bossio, Sabrina, Recchia, Anna Grazia, Moia, Riccardo, Pietrasanta, Daniela, Loseto, Giacomo, Consoli, Ugo, Scortechini, Ilaria, Rossi, Francesca Maria, Zucchetto, Antonella, Al-Janazreh, Hamdi, Vitale, Candida, Tripepi, Giovanni, D’Arrigo, Graziella, Angeletti, Ilaria, Bomben, Riccardo, Neri, Antonino, Cutrona, Giovanna, Fronza, Gilberto, Di Raimondo, Francesco, Gaidano, Gianluca, Cuneo, Antonio, Foà, Robin, Ferrarini, Manlio, Trentin, Livio, Gattei, Valter, Morabito, Fortunato
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/1541/1990/283/1895 692/699/1541/1990/291/1621/1915 Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - administration & dosage Biomedical and Life Sciences Biomedicine Cancer Research Correspondence Disease-Free Survival Female Hematology Humans Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - mortality Male Middle Aged Monoclonal antibodies Oncology Purines - administration & dosage Quinazolinones - administration & dosage Rituximab - administration & dosage Survival Rate Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	2044-5385 2044-5385
DOI:	10.1038/s41408-020-00358-3